SS
Serge Saxonov
Chief Executive Officer

Serge Saxonov insider trades: 10x Genomics (TXG) stock sales

Chief Executive Officer, 10x Genomics Last trade Sep 22, 2026 99 Form 4 filings
$6.8M
Sold, last 12 months
10 sales
$0
Bought, last 12 months
0 buys
68
Open-market trades
since 2020
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Serge reports to the SEC

Open-market buys and sales

68 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 22, 2026TXG↓ Sell$2.0M
Aug 26, 2026TXG↓ Sell$668K
Aug 24, 2026TXG↓ Sell$1.2M
Jun 22, 2026TXG↓ Sell$1.0M
May 26, 2026TXG↓ Sell$709K
Apr 14, 2026TXG↓ Sell$123K
Mar 24, 2026TXG↓ Sell$289K
Mar 2, 2026TXG↓ Sell$367K
Feb 23, 2026TXG↓ Sell$179K
Nov 24, 2025TXG↓ Sell$252K
Aug 22, 2025TXG↓ Sell$129K
May 22, 2025TXG↓ Sell$78K
Feb 28, 2025TXG↓ Sell$84K
Feb 24, 2025TXG↓ Sell$56K
Nov 22, 2024TXG↓ Sell$92K
Aug 22, 2024TXG↓ Sell$152K
May 22, 2024TXG↓ Sell$119K
Mar 4, 2024TXG↓ Sell$205K
Feb 22, 2024TXG↓ Sell$131K
Feb 15, 2024TXG↓ Sell$244K
Feb 9, 2024TXG↓ Sell$50K
Jan 16, 2024TXG↓ Sell$181K
Dec 14, 2023TXG↓ Sell$110K
Nov 24, 2023TXG↓ Sell$326K
Nov 14, 2023TXG↓ Sell$79K
Oct 17, 2023TXG↓ Sell$79K
Sep 14, 2023TXG↓ Sell$99K
Aug 22, 2023TXG↓ Sell$172K
Aug 14, 2023TXG↓ Sell$100K
Jul 19, 2023TXG↓ Sell$2.4M
Jul 14, 2023TXG↓ Sell$116K
Jun 14, 2023TXG↓ Sell$116K
May 23, 2023TXG↓ Sell$143K
May 15, 2023TXG↓ Sell$107K
Apr 14, 2023TXG↓ Sell$108K
Mar 14, 2023TXG↓ Sell$98K
Feb 22, 2023TXG↓ Sell$93K
Nov 22, 2022TXG↓ Sell$91K
Aug 23, 2022TXG↓ Sell$96K
May 23, 2022TXG↓ Sell$130K
Feb 22, 2022TXG↓ Sell$43K
Feb 8, 2022TXG↓ Sell$1.1M
Jan 4, 2022TXG↓ Sell$2.1M
Dec 7, 2021TXG↓ Sell$2.2M
Nov 22, 2021TXG↓ Sell$115K
Nov 2, 2021TXG↓ Sell$2.4M
Oct 5, 2021TXG↓ Sell$2.2M
Sep 7, 2021TXG↓ Sell$2.8M
Aug 23, 2021TXG↓ Sell$120K
Aug 3, 2021TXG↓ Sell$2.7M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TXG insiders

Open-market trades in the last 12 months

About Serge Saxonov's insider trades

Serge Saxonov is Chief Executive Officer at 10x Genomics (TXG). Since Mar 6, 2020, Serge has reported no open-market purchases and 68 sales worth $55.5M on SEC Form 4. In the last 12 months: 10 sales ($6.8M).

Their filings also include option exercises (36 filings), gifts (22 filings), grants and awards (9 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TXG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.